Interaction Checker

Interaksi Sevimelin

Sevimelin (Evoxac), golongan agonis kolinergik, memiliki 114 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 2 mayor, 28 moderat, 84 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Seperti apa tampilan Sevimelin

Semua 10 versi
Kapsul Sevimelin 30 mg: putih, 15 mm, dengan kode cetak EVOXAC 30 mg.
EVOXAC / 30 / mg
30 mg · putih · kapsul · 15 mm
Cosette
Kapsul Sevimelin 30 mg: putih, 16 mm, dengan kode cetak 1964.
1964
30 mg · putih · kapsul · 16 mm
Zydus Lifesciences
Kapsul Sevimelin 30 mg: cokelat, 16 mm, dengan kode cetak NL999 di satu sisi dan 30mg di sisi lainnya.
NL999 / 30mg
30 mg · cokelat · kapsul · 16 mm
Lupin Pharmaceuticals,Inc.
Kapsul Sevimelin 30 mg: putih, 16 mm, dengan kode cetak 54 di satu sisi dan 190 di sisi lainnya.
54 / 190
30 mg · putih · kapsul · 16 mm
Hikma Pharmaceuticals

Gambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 10 versi terdokumentasi dari 13 pelabel.

Interaksi dari label

Interaksi mayor (2)

  • IrinotekanMayor

    Early diarrhea may be accompanied by cholinergic symptoms which may be prevented or ameliorated by atropine. (label Irinotekan, Peringatan kotak hitam)

  • Rivastigminpenghambat kolinesteraseMayor

    Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended ( 7.1 , 7.2 , 7.3 ) (label Rivastigmin, Interaksi obat)

Interaksi moderat (28)

  • Asebutololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Atenololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Atenolol dan klortalidonpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Betaksololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Bisoprololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Bisoprolol dan hidroklorotiazidpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Brimonidin dan timololagonis alfa-adrenergikModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Donepezilpenghambat kolinesteraseModerat

    Peptic Ulcer Disease and GI Bleeding Through their primary action, cholinesterase inhibitors may be expected to increase gastric acid secretion due to increased cholinergic activity. (label Donepezil, Peringatan dan perhatian)

  • Dorzolamid dan timololpenghambat karbonat anhidraseModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Esmololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Galantaminpenghambat kolinesteraseModerat

    Gastrointestinal Conditions Through their primary action, cholinomimetics may be expected to increase gastric acid secretion due to increased cholinergic activity. (label Galantamin, Peringatan dan perhatian)

  • Hidrokodon dan klorfeniraminopioidModerat

    Additive adverse effects resulting from cholinergic blockade (e.g., xerostomia, blurred vision, or constipation) may occur when anticholinergic drugs are administered with chlorpheniramine. (label Hidrokodon dan klorfeniramin, Interaksi obat)

  • Karvedilolpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • KlozapinantipsikotikModerat

    Recurrence of Psychosis and Cholinergic Rebound after Abrupt Discontinuation of CLOZARIL If abrupt discontinuation of CLOZARIL is necessary (because of severe neutropenia or another medical condition, for example) [see Dosage and Administration ( 2.5 ), Warnings and Precautions ( 5.1 )] , monitor carefully for the recurrence of psychotic symptoms and adverse… (label Klozapin, Peringatan dan perhatian)

  • KuinidinantiaritmiaModerat

    Altered pharmacodynamics of other drugs: Quinidine's anticholinergic, vasodilating, and negative inotropic actions may be additive to those of other drugs with these effects, and antagonistic to those of drugs with cholinergic, vasoconstricting, and positive inotropic effects. (label Kuinidin, Interaksi obat)

  • Labetalolpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Memantin dan donepezilpenghambat kolinesteraseModerat

    Peptic Ulcer Disease and Gastrointestinal Bleeding Through their primary action, cholinesterase inhibitors may be expected to increase gastric acid secretion due to increased cholinergic activity. (label Memantin dan donepezil, Peringatan dan perhatian)

  • Metoprololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Metoprolol dan hidroklorotiazidpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Nadololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Nebivololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Neostigminpenghambat kolinesteraseModerat

    Cholinergic Crisis Overdosage of neostigmine may cause cholinesterase inhibitor toxicity or cholinergic crisis which may be difficult to differentiate from myasthenia crisis since both conditions present with similar symptoms. (label Neostigmin, Peringatan dan perhatian)

  • Pindololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Prometazin dan kodeinopioidModerat

    Additive adverse effects resulting from cholinergic blockade (e.g., xerostomia, blurred vision, or constipation) may occur when anticholinergic drugs are administered with promethazine]. (label Prometazin dan kodein, Interaksi obat)

  • Propranololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • SefpodoksimsefalosporinModerat

    Oral anti-cholinergics (e.g., propantheline) delay peak plasma levels (47% increase in Tmax), but do not affect the extent of absorption (AUC). (label Sefpodoksim, Interaksi obat)

  • Sotalolpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Timololpenyekat betaModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

Penyebutan minor (84)

  • Abirateronpenghambat CYP2D6Minor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • AklidiniumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • AmantadinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • AmiodaronantiaritmiaMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Amitriptilinantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Amoksapinantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • AtropinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Atropin dan pralidoksimantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Beladona dan opiumopioidMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • BenztropinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Bromfeniramin, pseudoefedrin, dan dekstrometorfanantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • BupropionantidepresanMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • DarifenasinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DarunavirantiretroviralMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Darunavir dan kobisistatantiretroviralMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • DeksklorfeniraminantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Dekstrometorfan dan kuinidinobat serotonergikMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Desipraminantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DifenhidraminantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DimenhidrinatantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DisikloverinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DisopiramidantiaritmiaMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Doksepinantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DoksilaminantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Doksilamin dan piridoksinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • DuloksetinSNRIMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Elvitegravir, kobisistat, emtrisitabin, dan tenofovirantiretroviralMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • EverolimusimunosupresanMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Fenobarbital, hiosiamin, atropin, dan skopolaminbarbituratMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • FesoterodinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • FlavoksatantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • FluoksetinSSRIMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • FluvoksaminSSRIMinor

    Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of tacrine. (label Fluvoksamin, Interaksi obat)

  • GlikopironiumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • HidroksizinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • HiosiaminantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Imatinibpenghambat CYP3A4Minor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Imipraminantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • IpratropiumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Ipratropium dan salbutamolantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • KarbinoksaminantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • KlemastinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • KlobazambenzodiazepinMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Klomipraminantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Klordiazepoksid dan klidiniumbenzodiazepinMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • KlorfeniraminantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • KlorpromazinantipsikotikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Lopinavir dan ritonavirantiretroviralMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • MeklizinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • MetskopolaminantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Mirabegronagonis beta-adrenergikMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Naltrekson dan bupropionantagonis opioidMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Nilotinibobat yang memperpanjang interval QTMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Nortriptilinantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • OksibutininantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • OlanzapinantipsikotikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Olanzapin dan fluoksetinantipsikotikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Orfenadrinpelemas ototMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Orfenadrin, aspirin, dan kafeinpelemas ototMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • ParoksetinSSRIMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • ProklorperazinantipsikotikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • PrometazinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Prometazin dan dekstrometorfanantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • PropafenonantiaritmiaMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Protriptilinantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Ranolazinobat yang memperpanjang interval QTMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • RitonavirantiretroviralMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Rolapitantpenghambat CYP2D6Minor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Siklobenzaprinpelemas ototMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • SiklopentolatantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Simetidinpenghambat H2Minor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • Sinakalsetpenghambat CYP2D6Minor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • SiproheptadinantihistaminMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • SkopolaminantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • SolifenasinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • TerbinafinantijamurMinor

    Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline. (label Sevimelin, Interaksi obat)

  • TioridazinantipsikotikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • TiotropiumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • TolterodinantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • TriheksifenidilantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Trimipraminantidepresan trisiklikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • TrospiumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • UmeklidiniumantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

  • Umeklidinium dan vilanterolantikolinergikMinor

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (label Sevimelin, Interaksi obat)

Periksa Sevimelin terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.